Clinical trials: Screening Mammogram
Breast Cancer
Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer
This research study is comparing Dual-Energy Contrast-Enhanced Spectral Mammography (CESM) to MRI as a screening tool for breast cancer.
- Trial name
- NCT02275871
- Testing
- MRI, CESM
- Where
- United States
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Beth Israel Deaconess Medical Center
Breast Cancer
Moderating the Negative Impact of Abnormal Screening Mammograms
This project evaluates the impact of CHESS-Mammo by assessing participants' health information competence, psychological distress, and satisfaction with their doctor as measured by previously validated survey questionnaires.
- Trial name
- NCT01153126
- Testing
- Comprehensive Health Enhancement Support System (CHESS.)
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- University of Wisconsin, Madison
Recall Rate, Cancer Detection Rate
Tomosynthesis in the Oslo Breast Cancer Screening Program
The Digital Breast Tomosynthesis (DBT) in the Oslo Mammography Screening Program will include women aged 50 to 69 years invited to the population-based mammography-screening program.
- Conditions
- Recall Rate, Cancer Detection Rate, False Positive Rate, Positive Predictive Value
- Trial name
- DBT (NCT01248546)
- Testing
- Digital breast tomosynthesis
- Where
- Norway
- Volunteers
- 25,000 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Breast Cancer
Automated Tele Counseling for Screening Mammography
The purpose and aim of this study is to test the use of a computer-based, automated telecommunications system and its effectiveness in increasing the rates of regular screening mammography among women ages 50-74.
- Trial name
- NCT00247013
- Testing
- Breast Cancer Screening Compliance
- Where
- United States
- Volunteers
- 2,120 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Breast Cancer Screening
Evaluation of an mHealth Intervention to Promote Participation in Breast Cancer Screening in Argentina
We carried out with a mixed-method study including a pragmatic randomized controlled trial to evaluate effectiveness of the intervention and quantitative and qualitative evaluation of the implementation from women and…
- Trial name
- NCT06500936
- Testing
- SMS
- Where
- Argentina
- Volunteers
- 248 people, healthy volunteers welcome
- Sponsor
- Centro de Estudio de Estado y Sociedad
Breast Neoplasms
Delphinus SoftVue Prospective Case Collection - ARM 2
The SoftVue™ is a whole breast ultrasound system with an automated scanning curvilinear ring-array transducer that employs UST. It is currently cleared under FDA 510(k) K123209 and K142517 for use as both a B-mode ultrasonic…
- Trial name
- SV PCC ARM2 (NCT02977247)
- Testing
- Non-Interventional, Automated Whole Breast Ultrasound
- Where
- 10 sites in United States
- Volunteers
- 1,150 people
- Sponsor
- Delphinus Medical Technologies, Inc.
Breast Cancer
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
To compare DBT and FFDM for screening effectiveness in women who present for screening mammography with respect to screening recall rate.
- Trial name
- NCT00535678
- Where
- United States
- Volunteers
- 400 people
- Sponsor
- GE Healthcare
DCIS, Breast Carcinoma in Situ
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
The study hypothesis is that the rate of inadequate surgical margins after conservative breast surgery for DICS and the rate of reoperation (re-excision or/and mastectomy) is lower in the group of patients who underwent standard…
- Conditions
- DCIS, Breast Carcinoma in Situ, Calcification
- Trial name
- CEMinDCIS (NCT06217458)
- Testing
- Contrast Enhanced Mammography
- Where
- Croatia
- Volunteers
- 100 people
- Sponsor
- Clinical Hospital Center Rijeka
Breast Cancer
Screening for Breast Cancer With Digital Breast Tomosynthesis
Randomized trial comparing the performance of tomosynthesis and 2D Digital Mammography vs 2D Digital Mammography only in respect to incidence of advanced cancers (interval and following round) and interval cancers.
- Trial name
- NCT02698202
- Testing
- Digital Breast Tomosynthesis
- Where
- Italy
- Volunteers
- 26,877 people
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
Breast Cancer
A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population
The primary aim of this study is to measure, document and compare recall rates of two-dimensional plus three dimensional (2D plus 3D) (Tomosynthesis) mammography to that of 2D mammography in a screening population.
- Trial name
- NCT01569802
- Where
- United States
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Rose Imaging Specialists, P.A.
Breast Cancer
Increasing Screening for Cancer Using EHR-Nudges Replication
In this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit.
- Trial name
- I-SCREEN Rep (NCT06995703)
- Testing
- Pre-Visit Patient Text Message, Post-Visit Patient Text Messages, Smart Data Element (SDE)
- Where
- United States
- Volunteers
- 8,490 people
- Sponsor
- Abramson Cancer Center at Penn Medicine
Breast Cancer, Screening
Artificial Intelligence in Breast Cancer Screening Programs
The use of artificial intelligence software in breast screening (Transpara®) makes it possible to identify studies with a very low probability of cancer.
- Trial name
- AITIC (NCT04949776)
- Testing
- Mammograms
- Where
- Spain
- Volunteers
- 31,301 people, healthy volunteers welcome
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba
Healthy Volunteers
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
The purpose of this study is find out if a protein level in the blood (called PC Cell Derived Growth Factor or glycoprotein 88 [GP88]), combined with standard mammography screening, can help detect breast cancer better than…
- Trial name
- 1380GCC (NCT02700776)
- Testing
- Phlebotomy - Blood sampling for GP88 at MM, SOC Tissue biopsy
- Where
- 2 sites in United States
- Volunteers
- 417 people, healthy volunteers welcome
- Sponsor
- University of Maryland, Baltimore
Breast Cancer
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
RATIONALE: Screening may help doctors find breast cancer cells early and plan better treatment for breast cancer. The Mammography FastTrack program may be effective in increasing the number of patients who undergo mammography.
- Trial name
- NCT00462891
- Testing
- IT System
- Where
- United States
- Volunteers
- 6,730 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Breast Cancer
Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study
This Breast Cancer Surveillance Consortium (BCSC) ADVANCE study is a large, observational pragmatic comparative effectiveness research study using high-quality, prospectively collected data from BCSC registries to generate…
- Trial name
- BCSC-ADVANCE (NCT02980848)
- Testing
- Screening digital mammography, Screening digital breast tomosynthesis, Screening breast magnetic resonance imaging
- Where
- 7 sites in United States
- Volunteers
- 1,341,172 people
- Sponsor
- University of California, Davis
Breast Cancer
English Mammography Screening Outcomes by Age, Frequency and Test Threshold
Breast cancer screening involves taking mammograms (x-rays) of women's breasts to search for signs of cancer. This study investigates the impact of test threshold, screening interval (frequency) and age of eligibility on…
- Trial name
- ATHENA-M (NCT05247463)
- Testing
- Increase in upper age of eligibility for breast cancer screening from 64 to 70, Screening round length, Screening test threshold
- Where
- United Kingdom
- Volunteers
- 10,000,000 people
- Sponsor
- University of Warwick
Breast Cancer Screening, Colon Cancer Screening
Bundled Cancer Screening and Genetic Services Navigation
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and…
- Conditions
- Breast Cancer Screening, Colon Cancer Screening, Genetics Predisposition
- Trial name
- NCT07228000
- Testing
- Breast cancer screening navigation, Multicancer screening navigation, Usual care genetics referral
- Where
- 2 sites in United States
- Volunteers
- 820 people, healthy volunteers welcome
- Sponsor
- Georgetown University
Breast Neoplasms
Australian Screening Mammography Decision Aid Trial (ASMDAT)
The purpose of the study is to develop and evaluate a decision aid to assist women aged 70 years and over to make an informed choice about whether to continue screening mammography.
- Trial name
- NCT00247442
- Testing
- Decision aid
- Where
- Australia
- Volunteers
- 670 people, healthy volunteers welcome
- Sponsor
- University of Sydney
Breast Cancer Screening and Diagnosis
Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial
Women at high risk of breast cancer (BC) should undergo annual magnetic resonance imaging (MRI) and digital mammography (DM) from at least ages 35 to 60.
- Trial name
- CEM (NCT06629896)
- Testing
- Contrast Enhancement Mammography, magnetic resonance imaging (MRI) and digital mammography (DM)
- Where
- Italy
- Volunteers
- 2,200 people
- Sponsor
- Azienda USL Reggio Emilia - IRCCS
Breast Density
Tomosynthesis in Screening Mammography
Tomosynthesis is a new digital mammographic tool which can be performed at the same time as routine screening mammography. It creates CT-like slices through the breast, minimizing the tissue overlap.
- Trial name
- NCT01086241
- Testing
- 2D Mammogram, Tomosynthesis
- Where
- Canada
- Volunteers
- 500 people
- Sponsor
- AHS Cancer Control Alberta